Clinuvel Pharmaceuticals (CH:UR9)
CHF 4.30+0.15 (+3.49%)
CH:UR9
Clinuvel Pharmaceuticals earnings date
CHF 4.30
At close:+0.15 (+3.49%)
Clinuvel Pharmaceuticals (UR9) Q2 2023 Earnings Report
0 Followers
CH:UR9 Q2 2023 EPS Results
- Actual EPS
- CHF 0.13
- Consensus EPS
- CHF 0.18
- Beat/Miss
- Missed by -CHF 0.05
- One Year Ago EPS
- CHF 0.06
CH:UR9 Q2 2023 Revenue Results
- Actual Revenue
- CHF 16.74M
- Expected Revenue
- CHF 18.49M
- Beat/Miss
- Missed by -CHF 1.76M
- YoY Revenue Growth
- +19.18%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 02/22/2023
- Time
- After Close
- Conference Call
- Wednesday, February 22, 2023
CH:UR9 Upcoming Earnings
Clinuvel Pharmaceuticals 's next earnings date is estimated for February 23, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:UR9 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 23, 2027 | 2027 (Q2) | 0.14- | 0.12 | ― | ― |
| Aug 27, 2026 | 2026 (Q4) | 0.290.27 | 0.25 | 7.06% (+0.02) | |
| Feb 25, 2026 | 2026 (Q2) | 0.170.12 | 0.16 | -26.43% (-0.04) | |
| Aug 27, 2025 | 2025 (Q4) | 0.160.25 | 0.28 | -11.13% (-0.03) | |
| Feb 26, 2025 | 2025 (Q2) | 0.120.16 | 0.12 | 32.08% (+0.04) | |
| Aug 29, 2024 | 2024 (Q4) | 0.250.28 | 0.22 | 30.34% (+0.07) | |
| Feb 21, 2024 | 2024 (Q2) | 0.150.12 | 0.13 | -3.64% (-0.00) | |
| Aug 29, 2023 | 2023 (Q4) | 0.210.22 | 0.17 | 24.67% (+0.04) | |
| Feb 22, 2023 | 2023 (Q2) | 0.180.13 | 0.06 | 92.98% (+0.06) | |
| Aug 30, 2022 | 2022 (Q4) | 0.250.17 | 0.2 | -14.85% (-0.03) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

